A Phase 2b/3 randomized, double-blind, placebo-controlled, parallel group, multicentre study investigating the efficacy and safety of JNJ54861911 in subjects who are asymptomatic at risk for develo... (2016-2022)
Experts
Professor
Gerard Byrne
Mayne Professor of Psychiatry
Medical School
Faculty of Health, Medicine and Behavioural Sciences
